Stefan Schulz

19.4k total citations · 1 hit paper
273 papers, 13.7k citations indexed

About

Stefan Schulz is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Epidemiology. According to data from OpenAlex, Stefan Schulz has authored 273 papers receiving a total of 13.7k indexed citations (citations by other indexed papers that have themselves been cited), including 138 papers in Molecular Biology, 111 papers in Cellular and Molecular Neuroscience and 90 papers in Epidemiology. Recurrent topics in Stefan Schulz's work include Receptor Mechanisms and Signaling (99 papers), Neuropeptides and Animal Physiology (90 papers) and Neuroendocrine Tumor Research Advances (85 papers). Stefan Schulz is often cited by papers focused on Receptor Mechanisms and Signaling (99 papers), Neuropeptides and Animal Physiology (90 papers) and Neuroendocrine Tumor Research Advances (85 papers). Stefan Schulz collaborates with scholars based in Germany, United States and United Kingdom. Stefan Schulz's co-authors include Volker Höllt, Ralf Stumm, Thomas Koch, Amelie Lupp, Manuela Pfeiffer, Helmut Schröder, V. Höllt, Matthias Schreff, MacDonald J. Christie and Manuela Händel and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Stefan Schulz

270 papers receiving 13.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regulation of µ-Opioid Receptors: Desensitization, Phosphorylation, Internalization, and Tolerance

2013 624 citations Graeme Henderson, Stefan Schulz et al. profile →

Peers

Countries citing papers authored by Stefan Schulz

Since Specialization

Citations

This map shows the geographic impact of Stefan Schulz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Schulz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Schulz more than expected).

Fields of papers citing papers by Stefan Schulz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Schulz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Schulz. The network helps show where Stefan Schulz may publish in the future.

Co-authorship network of co-authors of Stefan Schulz

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Schulz. A scholar is included among the top collaborators of Stefan Schulz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Schulz. Stefan Schulz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rapid elucidation of agonist-driven regulation of the neurokinin 1 receptor using a GPCR phosphorylation immunoassay 2024 ·European Journal of Pharmacology ·(unknown), Anne E. Schaffner, Julia Drube, Falko Nagel, Rainer K. Reinscheid, Carsten Hoffmann, Stefan Schulz	1
2	Identification of a Novel SSTR3 Full Agonist for the Treatment of Nonfunctioning Pituitary Adenomas 2023 ·Cancers ·Daniela Modena, Maria Luisa Moras, Giovanni Sandrone, Andrea Stevenazzi, Barbara Vergani, (unknown), (unknown), (unknown), (unknown), (unknown), Raúl M. Luque, (unknown), Natalia S. Pellegata, Stefan Schulz, Christian Steinkühler	4
3	Assessment of G Protein-Coupled Oestrogen Receptor Expression in Normal and Neoplastic Human Tissues Using a Novel Rabbit Monoclonal Antibody 2022 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), Daniel Kaemmerer, Jörg Sänger, Katja Evert, Ralph M. Wirtz, Stefan Schulz, Amelie Lupp	8
4	Agonist-induced phosphorylation of orthologues of the orphan receptor GPR35 functions as an activation sensor 2022 ·Journal of Biological Chemistry ·(unknown), Laura Jenkins, Amlan Ganguly, Adrian J. Butcher, Brian D. Hudson, Stefan Schulz, Andrew B. Tobin, Stuart A. Nicklin, Graeme Milligan	18
5	HA-MOP knockin mice express the canonical µ-opioid receptor but lack detectable splice variants 2021 ·Communications Biology ·Sebastian Fritzwanker, Lionel Moulédous, Catherine Mollereau, Carine Froment, Odile Burlet‐Schiltz, (unknown), Alexis Bailey, Mariana Spetea, Rainer K. Reinscheid, Stefan Schulz, Andrea Kliewer	6
6	Gender-Specific Efficacy Revealed by Head-to-Head Comparison of Pasireotide and Octreotide in a Representative In Vivo Model of Nonfunctioning Pituitary Tumors 2021 ·Cancers ·(unknown), Tobias Wiedemann, (unknown), (unknown), Amelie Lupp, Katja Steiger, Hsi-Yu Yen, (unknown), Johannes Notni, Raúl M. Luque, Herbert Schmid, Stefan Schulz, Donna P. Ankerst, Franz Schilling, Natalia S. Pellegata	9
7	Pharmacological Characterization of Veldoreotide as a Somatostatin Receptor 4 Agonist 2021 ·Life ·(unknown), Thomas Günther, Stefan Schulz	7
8	Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor 2020 ·Trends in Pharmacological Sciences ·Alexander Gillis, Andrea Kliewer, Eamonn Kelly, Graeme Henderson, MacDonald J. Christie, Stefan Schulz, Meritxell Canals	103
9	Comprehensive Assessment of GPR68 Expression in Normal and Neoplastic Human Tissues Using a Novel Rabbit Monoclonal Antibody 2019 ·International Journal of Molecular Sciences ·(unknown), (unknown), Daniel Kaemmerer, Jörg Sänger, Katja Evert, Stefan Schulz, Amelie Lupp	17
10	Agonist-selective NOP receptor phosphorylation correlates in vitro and in vivo and reveals differential post-activation signaling by chemically diverse agonists 2019 ·Science Signaling ·Anika Mann, Lionel Moulédous, Carine Froment, Patrick O’Neill, (unknown), Thomas Günther, (unknown), Brigitte L. Kieffer, Lawrence Toll, Michael R. Bruchas, Nurulain T. Zaveri, Stefan Schulz	31
11	The COMMD3/8 complex determines GRK6 specificity for chemoattractant receptors 2019 ·The Journal of Experimental Medicine ·Akiko Nakai, (unknown), Haruhiko Miyata, Ralf Stumm, Masashi Narazaki, Stefan Schulz, Yoshihiro Baba, Atsushi Kumanogoh, Kazuhiro Suzuki	25
12	Multisite phosphorylation is required for sustained interaction with GRKs and arrestins during rapid μ-opioid receptor desensitization 2018 ·Science Signaling ·Elke Miess, Arisbel B. Gondin, Arsalan Yousuf, (unknown), (unknown), Yunshi Yang, Martin G. Goldner, (unknown), Moritz Bünemann, Cornelius Krasel, MacDonald J. Christie, Michelle L. Halls, Stefan Schulz, Meritxell Canals	91
13	Neuropeptide S precursor knockout mice display memory and arousal deficits 2017 ·European Journal of Neuroscience ·Xiaobin Liu, Si Wei, Celia Garau, Kay Jüngling, Hans‐Christian Pape, Stefan Schulz, Rainer K. Reinscheid	20
14	Comparison of immunoreactive score, HER2/neu score and H score for the immunohistochemical evaluation of somatostatin receptors in bronchopulmonary neuroendocrine neoplasms 2015 ·Histopathology ·(unknown), Daniel Kaemmerer, Jörg Sänger, Ralph M. Wirtz, Stefan Schulz, Amelie Lupp	131
15	Comparing of IRS and Her2 as immunohistochemical scoring schemes in gastroenteropancreatic neuroendocrine tumors. 2012 ·PubMed ·Daniel Kaemmerer, Luisa Peter, Amelie Lupp, Stefan Schulz, Jörg Sänger, Richard P. Baum, Vikas Prasad, Merten Hommann	114
16	Pasireotide and Octreotide Stimulate Distinct Patterns of sst2A Somatostatin Receptor Phosphorylation 2010 ·Molecular Endocrinology ·(unknown), Diana Lehmann, (unknown), Mihaela Ginj, Stefan Jacobs, Amelie Lupp, Ralf Stumm, Stefan Schulz	79
17	Survey of current terminologies and ontologies in biology and medicine - DOI: 10.3395/reciis.v3i1.239en 2009 ·SHILAP Revista de lepidopterología ·Frederico Freitas, Stefan Schulz, (unknown)	3
18	Differential Effects of Octreotide and Pasireotide on Somatostatin Receptor Internalization and Trafficking in Vitro 2008 ·The Journal of Clinical Endocrinology & Metabolism ·(unknown), Diana Lehmann, Falko Nagel, Herbert Schmid, Stefan Schulz	137
19	Neurologische Komplikationen und Wirkverlust unter intrathekaler Schmerztherapie: Drei Fallberichte und Auswertung der Literatur 2005 ·Der Schmerz ·(unknown), Christoph Maier, (unknown), Stefan Schulz, Thomas Weiß, M. Zenz	1
20	Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A. 2000 ·PubMed ·Stefan Schulz, (unknown), Manuela Händel, Knut Dietzmann, (unknown), Volker Höllt	147

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact